139 related articles for article (PubMed ID: 34288813)
1. WT1 inhibits AML cell proliferation in a p53-dependent manner.
Yao Y; Chai X; Gong C; Zou L
Cell Cycle; 2021 Aug; 20(16):1552-1560. PubMed ID: 34288813
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
Lyu Y; Lou J; Yang Y; Feng J; Hao Y; Huang S; Yin L; Xu J; Huang D; Ma B; Zou D; Wang Y; Zhang Y; Zhang B; Chen P; Yu K; Lam EW; Wang X; Liu Q; Yan J; Jin B
Leukemia; 2017 Dec; 31(12):2543-2551. PubMed ID: 28400619
[TBL] [Abstract][Full Text] [Related]
3. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.
Wang Y; Xiao M; Chen X; Chen L; Xu Y; Lv L; Wang P; Yang H; Ma S; Lin H; Jiao B; Ren R; Ye D; Guan KL; Xiong Y
Mol Cell; 2015 Feb; 57(4):662-673. PubMed ID: 25601757
[TBL] [Abstract][Full Text] [Related]
4. Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1.
Potluri S; Assi SA; Chin PS; Coleman DJL; Pickin A; Moriya S; Seki N; Heidenreich O; Cockerill PN; Bonifer C
Cell Rep; 2021 Apr; 35(3):109010. PubMed ID: 33882316
[TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
Ullmark T; Montano G; Järvstråt L; Jernmark Nilsson H; Håkansson E; Drott K; Nilsson B; Vidovic K; Gullberg U
Biochem Biophys Res Commun; 2017 Jan; 482(4):802-807. PubMed ID: 27889611
[TBL] [Abstract][Full Text] [Related]
6. PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia.
Li B; Hu J; He D; Chen Q; Liu S; Zhu X; Yu M
Technol Cancer Res Treat; 2020; 19():1533033820942312. PubMed ID: 32691668
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
[TBL] [Abstract][Full Text] [Related]
8. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
[TBL] [Abstract][Full Text] [Related]
9. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
Idelman G; Glaser T; Roberts CT; Werner H
J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
[TBL] [Abstract][Full Text] [Related]
10. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Irish JM; Anensen N; Hovland R; Skavland J; Børresen-Dale AL; Bruserud O; Nolan GP; Gjertsen BT
Blood; 2007 Mar; 109(6):2589-96. PubMed ID: 17105820
[TBL] [Abstract][Full Text] [Related]
11. Higher Expression of
Chen C; Chen Z; Chio CL; Zhao Y; Li Y; Liu Z; Jin Z; Wu X; Wei W; Zhao Q; Li Y
Technol Cancer Res Treat; 2021; 20():15330338211052152. PubMed ID: 34738847
[No Abstract] [Full Text] [Related]
12. Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.
Prokocimer M; Molchadsky A; Rotter V
Blood; 2017 Aug; 130(6):699-712. PubMed ID: 28607134
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
Bartkowiak J; Wójcik I; Stankiewicz W
Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
[TBL] [Abstract][Full Text] [Related]
14. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H
Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Hollink IH; van den Heuvel-Eibrink MM; Zimmermann M; Balgobind BV; Arentsen-Peters ST; Alders M; Willasch A; Kaspers GJ; Trka J; Baruchel A; de Graaf SS; Creutzig U; Pieters R; Reinhardt D; Zwaan CM
Blood; 2009 Jun; 113(23):5951-60. PubMed ID: 19171881
[TBL] [Abstract][Full Text] [Related]
16. miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level.
Gao SM; Xing CY; Chen CQ; Lin SS; Dong PH; Yu FJ
J Exp Clin Cancer Res; 2011 Dec; 30(1):110. PubMed ID: 22133358
[TBL] [Abstract][Full Text] [Related]
17. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.
Zhou H; Zhang Q; Huang W; He C; Zhou C; Zhou J; Ning Y
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052262
[TBL] [Abstract][Full Text] [Related]
20. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
